{"id":{"repo_id":"greece","oai_identifier":"oai:10442/0443"},"canonical_url":"https://search.dev.ndltd.org/etd/greece/oai:10442/0443","repository":{"repo_id":"greece","name":"Greek National Archive of PhD Theses","base_url":"https://phdtheses.ekt.gr/eadd_oai/request"},"display":{"title":"ΣΥΜΒΟΛΗ ΕΙΣ ΤΗΝ ΠΡΟΓΝΩΣΤΙΚΗΝ ΣΗΜΑΣΙΑΝ ΤΩΝ ΠΑΡΑΜΕΤΡΩΝ ΤΗΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ","abstract":"FROM THE FOLLOW-UP AT LEAST FOR ONE YEAR OF 96,8% OF THE CASES OF ONE INITIAL COHORT OF 530 SUBJECTS OF BOTH SEXES WITH A WIDE RANGE OF CHEST COMPLAINS AND OR REST REPOLARIZATION CHANGES SUBJECTED TO ONE ECGPHIC STRESS TEST, ARE DRAWNTHE FOLLOWING CONCLUSIONS. 1. AS IT CONCERNS THE EVOLUTION OF SYMPTOMATOLOGY:A) ASYMPTOMATICS 20% (FROM A 6%) INITIALLY. B) SYMPTOMATIC IMPROVEMENT 23,9%,C) UNCHANGED SYMPTOMATOLOGY 40,3%, D) WORSENING OF SYMPTOMS 4,5%, E) NO LETHAL CARDIAC EVENTS 4,3%. 2. MORTALITY TOTAL 2,7% AND CARDIAC 1,7%. 3. OF THE PARAMETERS OF THE INITIAL DATA THE FOLLOWING WERE UNRELATED TO SYMPTOMATIC EVOLUTION A) SEX, B) AGE, C) INITIAL REST REPOLARIZATION CHANGES, D) DURATION OF EXERCISE TESTING, E) SMOKING. 4. INSTEAD THE FOLLOWING PARAMETERS WERE RELATED AND PREDICTIVE OF THE LATE SYMPTOMATIC OUTCOME, A) KIND OF INITIAL COMPLAINS, B) REST HEART RATE, C) POST EXERCISE HEART RATE, D) POST EXERCISE ECGPHIC CHANGES. 5. DRUG CONSUMED DURING THE FOLLOW-UP DO NOT ACCOUNT FOR THE IMPROVEMENT OF SYMPTOMS. 6. THE LETHAL OUTCOME IS ESSENTIALLY PREDICTED ONLY BY LOW POST-EXERCISE HEART RATES. THUS IT CAN SAID THAT SYMPTOMATIC EVOLUTION AND SURVIVAL OF CASES AS THOSE STUDIED HEREIN IS BETTER THAN BELIEVED SO FAR AND ALSO THAT CERTAIN CLINICAL AND ESPECIALLY POST EXERCISE PARAMETERS ARE PREDICTIVE IN A CERTAIN DEGREE OF THE FATE UNSELECTED CASES WITH A WIDE RANGE OF CHEST COMPLAINS.","abstract_html":"FROM THE FOLLOW-UP AT LEAST FOR ONE YEAR OF 96,8% OF THE CASES OF ONE INITIAL COHORT OF 530 SUBJECTS OF BOTH SEXES WITH A WIDE RANGE OF CHEST COMPLAINS AND OR REST REPOLARIZATION CHANGES SUBJECTED TO ONE ECGPHIC STRESS TEST, ARE DRAWNTHE FOLLOWING CONCLUSIONS. 1. AS IT CONCERNS THE EVOLUTION OF SYMPTOMATOLOGY:A) ASYMPTOMATICS 20% (FROM A 6%) INITIALLY. B) SYMPTOMATIC IMPROVEMENT 23,9%,C) UNCHANGED SYMPTOMATOLOGY 40,3%, D) WORSENING OF SYMPTOMS 4,5%, E) NO LETHAL CARDIAC EVENTS 4,3%. 2. MORTALITY TOTAL 2,7% AND CARDIAC 1,7%. 3. OF THE PARAMETERS OF THE INITIAL DATA THE FOLLOWING WERE UNRELATED TO SYMPTOMATIC EVOLUTION A) SEX, B) AGE, C) INITIAL REST REPOLARIZATION CHANGES, D) DURATION OF EXERCISE TESTING, E) SMOKING. 4. INSTEAD THE FOLLOWING PARAMETERS WERE RELATED AND PREDICTIVE OF THE LATE SYMPTOMATIC OUTCOME, A) KIND OF INITIAL COMPLAINS, B) REST HEART RATE, C) POST EXERCISE HEART RATE, D) POST EXERCISE ECGPHIC CHANGES. 5. DRUG CONSUMED DURING THE FOLLOW-UP DO NOT ACCOUNT FOR THE IMPROVEMENT OF SYMPTOMS. 6. THE LETHAL OUTCOME IS ESSENTIALLY PREDICTED ONLY BY LOW POST-EXERCISE HEART RATES. THUS IT CAN SAID THAT SYMPTOMATIC EVOLUTION AND SURVIVAL OF CASES AS THOSE STUDIED HEREIN IS BETTER THAN BELIEVED SO FAR AND ALSO THAT CERTAIN CLINICAL AND ESPECIALLY POST EXERCISE PARAMETERS ARE PREDICTIVE IN A CERTAIN DEGREE OF THE FATE UNSELECTED CASES WITH A WIDE RANGE OF CHEST COMPLAINS.","abstract_has_math":false,"creators":["Φρούντζος, Νικόλαος"],"institution":"National and Kapodistrian University of Athens","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1986,"date_issued":"1986","date_published":"1986","updated_at":"2026-07-24T02:25:14Z","subjects":["DRUG CONSUMATION","DURATION EXERCISE TESTING","Exercise testing","POST EXERCISE HEART RATE","SYMPTOMATIC AND ASYMPTOMATIC PATIENTS","ΔΙΑΡΚΕΙΑ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ","Δοκιμασία κοπώσεως","ΚΑΡΔΙΑΚΗ ΣΥΧΝΟΤΗΣ ΠΕΡΑΤΟΣ ΔΟΚΙΜΑΣΙΑΣ","ΣΥΜΠΤΩΜΑΤΙΚΟΙ ΚΑΙ ΑΣΥΜΠΤΩΜΑΤΙΚΟΙ ΑΣΘΕΝΕΙΣ","ΦΑΡΜΑΚΕΥΤΙΚΗ ΛΗΨΗ","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"],"languages":["gre"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0443"],"render_values":[{"text":"10.12681/eadd/0443","href":"https://doi.org/10.12681/eadd/0443","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/10442/hedi/0443","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Φρούντζος, Νικόλαος"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1986"]},{"key":"dc:publisher","label":"Institution","values":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"]},{"key":"dc:type","label":"Dc Type","values":["PhD Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["DRUG CONSUMATION","DURATION EXERCISE TESTING","Exercise testing","POST EXERCISE HEART RATE","SYMPTOMATIC AND ASYMPTOMATIC PATIENTS","ΔΙΑΡΚΕΙΑ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ","Δοκιμασία κοπώσεως","ΚΑΡΔΙΑΚΗ ΣΥΧΝΟΤΗΣ ΠΕΡΑΤΟΣ ΔΟΚΙΜΑΣΙΑΣ","ΣΥΜΠΤΩΜΑΤΙΚΟΙ ΚΑΙ ΑΣΥΜΠΤΩΜΑΤΙΚΟΙ ΑΣΘΕΝΕΙΣ","ΦΑΡΜΑΚΕΥΤΙΚΗ ΛΗΨΗ","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["gre"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0443","http://hdl.handle.net/10442/hedi/0443"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["FROM THE FOLLOW-UP AT LEAST FOR ONE YEAR OF 96,8% OF THE CASES OF ONE INITIAL COHORT OF 530 SUBJECTS OF BOTH SEXES WITH A WIDE RANGE OF CHEST COMPLAINS AND OR REST REPOLARIZATION CHANGES SUBJECTED TO ONE ECGPHIC STRESS TEST, ARE DRAWNTHE FOLLOWING CONCLUSIONS. 1. AS IT CONCERNS THE EVOLUTION OF SYMPTOMATOLOGY:A) ASYMPTOMATICS 20% (FROM A 6%) INITIALLY. B) SYMPTOMATIC IMPROVEMENT 23,9%,C) UNCHANGED SYMPTOMATOLOGY 40,3%, D) WORSENING OF SYMPTOMS 4,5%, E) NO LETHAL CARDIAC EVENTS 4,3%. 2. MORTALITY TOTAL 2,7% AND CARDIAC 1,7%. 3. OF THE PARAMETERS OF THE INITIAL DATA THE FOLLOWING WERE UNRELATED TO SYMPTOMATIC EVOLUTION A) SEX, B) AGE, C) INITIAL REST REPOLARIZATION CHANGES, D) DURATION OF EXERCISE TESTING, E) SMOKING. 4. INSTEAD THE FOLLOWING PARAMETERS WERE RELATED AND PREDICTIVE OF THE LATE SYMPTOMATIC OUTCOME, A) KIND OF INITIAL COMPLAINS, B) REST HEART RATE, C) POST EXERCISE HEART RATE, D) POST EXERCISE ECGPHIC CHANGES. 5. DRUG CONSUMED DURING THE FOLLOW-UP DO NOT ACCOUNT FOR THE IMPROVEMENT OF SYMPTOMS. 6. THE LETHAL OUTCOME IS ESSENTIALLY PREDICTED ONLY BY LOW POST-EXERCISE HEART RATES. THUS IT CAN SAID THAT SYMPTOMATIC EVOLUTION AND SURVIVAL OF CASES AS THOSE STUDIED HEREIN IS BETTER THAN BELIEVED SO FAR AND ALSO THAT CERTAIN CLINICAL AND ESPECIALLY POST EXERCISE PARAMETERS ARE PREDICTIVE IN A CERTAIN DEGREE OF THE FATE UNSELECTED CASES WITH A WIDE RANGE OF CHEST COMPLAINS.","ΕΚ ΤΗΣ ΠΑΡΑΚΟΛΟΥΘΗΣΕΩΣ ΕΠΙ ΕΝ ΕΤΟΣ ΤΟΥΛΑΧΙΣΤΟΝ ΤΟΥ 96,8% ΜΙΑΣ ΟΜΑΔΟΣ ΕΚ 530 ΑΤΟΜΩΝ ΑΡΧΙΚΩΣ, ΑΜΦΟΤΕΡΩΝ ΤΩΝ ΦΥΛΩΝ ΜΕΤΑ ΕΥΡΕΩΣ ΦΑΣΜΑΤΟΣ ΘΩΡΑΚΙΚΩΝ ΑΙΤΙΑΣΕΩΝ 'Η ΚΑΙ ΗΚΓ/ΩΝ ΑΛΛΟΙΩΣΕΩΝ, ΚΑΙ ΥΠΟΒΛΗΘΕΝΤΩΝ ΕΙΣ ΗΚΓ/ΚΗΝ ΔΟΚΙΜΑΣΙΑΝ ΚΟΠΩΣΕΩΣ ΠΡΟΕΚΥΨΑΝ ΤΑ ΚΑΤΩΘΙ ΕΙΣ ΤΟ ΠΕΡΑΣ ΤΟΥ ΧΡΟΝΟΥ ΠΑΡΑΚΟΛΟΥΘΗΣΕΩΣ: 1. ΑΠΟ ΑΠΟΨΕΩΣ ΕΞΕΛΙΞΕΩΣ ΤΗΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ: Α) ΑΣΥΜΠΤΩΜΑΤΙΚΑΙ 20% (ΕΚ ΤΟΥ ΑΡΧΙΚΟΥ 6%), Β) ΒΕΛΤΙΩΣΗΤΗΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ 23,9%, Γ) ΑΜΕΤΑΒΛΗΤΟΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑ 40,3%, Δ) ΕΠΙΔΕΙΝΩΣΗ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ 8,5%, Ε) ΜΗ ΘΑΝΑΤΗΦΟΡΑ ΚΑΡΔΙΑΚΑ ΣΥΜΒΑΝΤΑ 43%. 2. ΘΝΗΤΟΤΗΣΣΥΝΟΛΙΚΗ ΜΕΝ 2,7% ΚΑΡΔΙΑΚΗΣ ΠΡΟΕΛΕΥΣΕΩΣ ΜΟΝΟ 1,7%. 3. ΠΑΡΑΜΕΤΡΟΙ ΤΟΥ ΑΡΧΙΚΟΥ ΕΛΕΓΧΟΥ ΜΗ ΣΧΕΤΙΖΟΜΕΝΑΙ ΜΕ ΤΗΝ ΣΥΜΠΤΩΜΑΤΙΚΗ ΕΞΕΛΙΞΗΝ ΗΤΑΝ ΤΑ ΕΞΗΣ: Α) ΦΥΛΟΝ, Β) ΗΛΙΚΙΑ, Γ) ΗΚΓ/ΚΗ ΕΠΑΝΑΚΤΗΣΗ ΗΡΕΜΙΑΣ, Δ) ΔΙΑΡΚΕΙΑ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ, Ε) ΚΑΠΝΙΣΜΑ. 4. ΠΑΡΑΜΕΤΡΟΙ ΤΟΥ ΑΡΧΙΚΟΥ ΕΛΕΓΧΟΥ ΣΥΣΧΕΤΙΖΟΜΕΝΑΙ ΜΕ ΤΗΝ ΠΕΡΑΙΤΕΡΩ ΣΥΜΠΤΩΜΑΤΙΚΗ ΕΞΕΛΙΞΙΝ ΗΣΑΝ: Α) ΠΟΙΟΤΗΣ ΚΑΙ ΕΙΔΟΣ ΑΡΧΙΚΗΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ, Β) ΚΑΡΔΙΑΚΗ ΣΥΧΝΟΤΗΣ ΗΡΕΜΙΑΣ, Γ) ΗΚΓ/ΚΑΙ ΜΕΤΑΒΟΛΑΙ ΜΕΤΑ ΚΟΠΩΣΙΝ, Δ) ΚΑΡΔΙΑΚΗ ΣΥΧΝΟΤΗΣΠΕΡΑΤΟΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ. 5. Η ΛΗΨΙΣ ΦΑΡΜΑΚΩΝ ΔΕΝ ΗΤΟ ΥΠΟΛΟΓΟΣ ΔΙΑ ΤΗΝ ΥΠΟΚΕΙΜΕΝΙΚΗΝ ΒΕΛΤΙΩΣΙΝ. 6. Η ΘΑΝΑΤΗΦΟΡΟΣ ΕΚΒΑΣΙΣ ΠΡΟΥΔΙΚΑΖΕΤΟ ΑΞΙΟΛΟΓΟΣ, ΟΥΣΙΑΣΤΙΚΩΣ ΜΟΝΟ ΕΙΣ ΤΑΠΕΙΝΑΣ ΚΑΡΔΙΑΚΑΣ ΣΥΧΝΟΤΗΤΑΣ ΕΙΣ ΤΟ ΠΕΡΑΣ ΤΗΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ. ΕΝ ΚΑΤΑΚΛΕΙΔΙ ΤΟΣΟΝ Η ΣΥΜΠΤΩΜΑΤΙΚΗ ΕΚΒΑΣΙΣ ΟΣΟΝ ΚΑΙ Η ΕΠΙΒΙΩΣΙΣ ΜΗ ΕΠΙΛΕΓΕΝΤΩΝ ΑΤΟΜΩΝ ΜΕΤΑ ΘΩΡΑΚΙΚΩΝ ΑΛΓΩΝ ΕΙΝΑΙ ΠΕΡΙΣΣΟΤΕΡΟΝ ΕΥΝΟΙΚΗ ΑΠ'ΟΤΙ ΚΟΙΝΩΣ ΠΙΣΤΕΥΕΤΑΙ ΕΝΩ ΠΑΡΑΛΛΗΛΩΣ ΕΠΙΣΗΜΑΝΘΗΚΑΝ ΚΛΙΝΙΚΑ ΚΑΙ ΚΥΡΙΩΣ ΕΚ ΤΗΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ ΚΡΙΤΗΡΙΑ ΑΥΤΑ ΕΙΝΑΙ ΔΥΝΑΤΟΝ ΕΙΣ ΤΟΝ ΒΑΘΜΟΝ ΝΑ ΠΡΟΒΛΕΨΟΥΝ ΤΗΝ ΤΥΧΗΝ ΤΩΝ ΑΤΟΜΩΝ ΑΥΤΩΝ."]},{"key":"dc:title","label":"Title","values":["ΣΥΜΒΟΛΗ ΕΙΣ ΤΗΝ ΠΡΟΓΝΩΣΤΙΚΗΝ ΣΗΜΑΣΙΑΝ ΤΩΝ ΠΑΡΑΜΕΤΡΩΝ ΤΗΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ","CONTRIBUTION TO THE PROGNOSTIC VALUE OF EXERCISE TESTING"]}]}],"canonical_facts":{"dc:creator":["Φρούντζος, Νικόλαος"],"dc:date":["1986"],"dc:description":["FROM THE FOLLOW-UP AT LEAST FOR ONE YEAR OF 96,8% OF THE CASES OF ONE INITIAL COHORT OF 530 SUBJECTS OF BOTH SEXES WITH A WIDE RANGE OF CHEST COMPLAINS AND OR REST REPOLARIZATION CHANGES SUBJECTED TO ONE ECGPHIC STRESS TEST, ARE DRAWNTHE FOLLOWING CONCLUSIONS. 1. AS IT CONCERNS THE EVOLUTION OF SYMPTOMATOLOGY:A) ASYMPTOMATICS 20% (FROM A 6%) INITIALLY. B) SYMPTOMATIC IMPROVEMENT 23,9%,C) UNCHANGED SYMPTOMATOLOGY 40,3%, D) WORSENING OF SYMPTOMS 4,5%, E) NO LETHAL CARDIAC EVENTS 4,3%. 2. MORTALITY TOTAL 2,7% AND CARDIAC 1,7%. 3. OF THE PARAMETERS OF THE INITIAL DATA THE FOLLOWING WERE UNRELATED TO SYMPTOMATIC EVOLUTION A) SEX, B) AGE, C) INITIAL REST REPOLARIZATION CHANGES, D) DURATION OF EXERCISE TESTING, E) SMOKING. 4. INSTEAD THE FOLLOWING PARAMETERS WERE RELATED AND PREDICTIVE OF THE LATE SYMPTOMATIC OUTCOME, A) KIND OF INITIAL COMPLAINS, B) REST HEART RATE, C) POST EXERCISE HEART RATE, D) POST EXERCISE ECGPHIC CHANGES. 5. DRUG CONSUMED DURING THE FOLLOW-UP DO NOT ACCOUNT FOR THE IMPROVEMENT OF SYMPTOMS. 6. THE LETHAL OUTCOME IS ESSENTIALLY PREDICTED ONLY BY LOW POST-EXERCISE HEART RATES. THUS IT CAN SAID THAT SYMPTOMATIC EVOLUTION AND SURVIVAL OF CASES AS THOSE STUDIED HEREIN IS BETTER THAN BELIEVED SO FAR AND ALSO THAT CERTAIN CLINICAL AND ESPECIALLY POST EXERCISE PARAMETERS ARE PREDICTIVE IN A CERTAIN DEGREE OF THE FATE UNSELECTED CASES WITH A WIDE RANGE OF CHEST COMPLAINS.","ΕΚ ΤΗΣ ΠΑΡΑΚΟΛΟΥΘΗΣΕΩΣ ΕΠΙ ΕΝ ΕΤΟΣ ΤΟΥΛΑΧΙΣΤΟΝ ΤΟΥ 96,8% ΜΙΑΣ ΟΜΑΔΟΣ ΕΚ 530 ΑΤΟΜΩΝ ΑΡΧΙΚΩΣ, ΑΜΦΟΤΕΡΩΝ ΤΩΝ ΦΥΛΩΝ ΜΕΤΑ ΕΥΡΕΩΣ ΦΑΣΜΑΤΟΣ ΘΩΡΑΚΙΚΩΝ ΑΙΤΙΑΣΕΩΝ 'Η ΚΑΙ ΗΚΓ/ΩΝ ΑΛΛΟΙΩΣΕΩΝ, ΚΑΙ ΥΠΟΒΛΗΘΕΝΤΩΝ ΕΙΣ ΗΚΓ/ΚΗΝ ΔΟΚΙΜΑΣΙΑΝ ΚΟΠΩΣΕΩΣ ΠΡΟΕΚΥΨΑΝ ΤΑ ΚΑΤΩΘΙ ΕΙΣ ΤΟ ΠΕΡΑΣ ΤΟΥ ΧΡΟΝΟΥ ΠΑΡΑΚΟΛΟΥΘΗΣΕΩΣ: 1. ΑΠΟ ΑΠΟΨΕΩΣ ΕΞΕΛΙΞΕΩΣ ΤΗΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ: Α) ΑΣΥΜΠΤΩΜΑΤΙΚΑΙ 20% (ΕΚ ΤΟΥ ΑΡΧΙΚΟΥ 6%), Β) ΒΕΛΤΙΩΣΗΤΗΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ 23,9%, Γ) ΑΜΕΤΑΒΛΗΤΟΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑ 40,3%, Δ) ΕΠΙΔΕΙΝΩΣΗ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ 8,5%, Ε) ΜΗ ΘΑΝΑΤΗΦΟΡΑ ΚΑΡΔΙΑΚΑ ΣΥΜΒΑΝΤΑ 43%. 2. ΘΝΗΤΟΤΗΣΣΥΝΟΛΙΚΗ ΜΕΝ 2,7% ΚΑΡΔΙΑΚΗΣ ΠΡΟΕΛΕΥΣΕΩΣ ΜΟΝΟ 1,7%. 3. ΠΑΡΑΜΕΤΡΟΙ ΤΟΥ ΑΡΧΙΚΟΥ ΕΛΕΓΧΟΥ ΜΗ ΣΧΕΤΙΖΟΜΕΝΑΙ ΜΕ ΤΗΝ ΣΥΜΠΤΩΜΑΤΙΚΗ ΕΞΕΛΙΞΗΝ ΗΤΑΝ ΤΑ ΕΞΗΣ: Α) ΦΥΛΟΝ, Β) ΗΛΙΚΙΑ, Γ) ΗΚΓ/ΚΗ ΕΠΑΝΑΚΤΗΣΗ ΗΡΕΜΙΑΣ, Δ) ΔΙΑΡΚΕΙΑ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ, Ε) ΚΑΠΝΙΣΜΑ. 4. ΠΑΡΑΜΕΤΡΟΙ ΤΟΥ ΑΡΧΙΚΟΥ ΕΛΕΓΧΟΥ ΣΥΣΧΕΤΙΖΟΜΕΝΑΙ ΜΕ ΤΗΝ ΠΕΡΑΙΤΕΡΩ ΣΥΜΠΤΩΜΑΤΙΚΗ ΕΞΕΛΙΞΙΝ ΗΣΑΝ: Α) ΠΟΙΟΤΗΣ ΚΑΙ ΕΙΔΟΣ ΑΡΧΙΚΗΣ ΣΥΜΠΤΩΜΑΤΟΛΟΓΙΑΣ, Β) ΚΑΡΔΙΑΚΗ ΣΥΧΝΟΤΗΣ ΗΡΕΜΙΑΣ, Γ) ΗΚΓ/ΚΑΙ ΜΕΤΑΒΟΛΑΙ ΜΕΤΑ ΚΟΠΩΣΙΝ, Δ) ΚΑΡΔΙΑΚΗ ΣΥΧΝΟΤΗΣΠΕΡΑΤΟΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ. 5. Η ΛΗΨΙΣ ΦΑΡΜΑΚΩΝ ΔΕΝ ΗΤΟ ΥΠΟΛΟΓΟΣ ΔΙΑ ΤΗΝ ΥΠΟΚΕΙΜΕΝΙΚΗΝ ΒΕΛΤΙΩΣΙΝ. 6. Η ΘΑΝΑΤΗΦΟΡΟΣ ΕΚΒΑΣΙΣ ΠΡΟΥΔΙΚΑΖΕΤΟ ΑΞΙΟΛΟΓΟΣ, ΟΥΣΙΑΣΤΙΚΩΣ ΜΟΝΟ ΕΙΣ ΤΑΠΕΙΝΑΣ ΚΑΡΔΙΑΚΑΣ ΣΥΧΝΟΤΗΤΑΣ ΕΙΣ ΤΟ ΠΕΡΑΣ ΤΗΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ. ΕΝ ΚΑΤΑΚΛΕΙΔΙ ΤΟΣΟΝ Η ΣΥΜΠΤΩΜΑΤΙΚΗ ΕΚΒΑΣΙΣ ΟΣΟΝ ΚΑΙ Η ΕΠΙΒΙΩΣΙΣ ΜΗ ΕΠΙΛΕΓΕΝΤΩΝ ΑΤΟΜΩΝ ΜΕΤΑ ΘΩΡΑΚΙΚΩΝ ΑΛΓΩΝ ΕΙΝΑΙ ΠΕΡΙΣΣΟΤΕΡΟΝ ΕΥΝΟΙΚΗ ΑΠ'ΟΤΙ ΚΟΙΝΩΣ ΠΙΣΤΕΥΕΤΑΙ ΕΝΩ ΠΑΡΑΛΛΗΛΩΣ ΕΠΙΣΗΜΑΝΘΗΚΑΝ ΚΛΙΝΙΚΑ ΚΑΙ ΚΥΡΙΩΣ ΕΚ ΤΗΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ ΚΡΙΤΗΡΙΑ ΑΥΤΑ ΕΙΝΑΙ ΔΥΝΑΤΟΝ ΕΙΣ ΤΟΝ ΒΑΘΜΟΝ ΝΑ ΠΡΟΒΛΕΨΟΥΝ ΤΗΝ ΤΥΧΗΝ ΤΩΝ ΑΤΟΜΩΝ ΑΥΤΩΝ."],"dc:identifier":["10.12681/eadd/0443","http://hdl.handle.net/10442/hedi/0443"],"dc:language":["gre"],"dc:publisher":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"],"dc:subject":["DRUG CONSUMATION","DURATION EXERCISE TESTING","Exercise testing","POST EXERCISE HEART RATE","SYMPTOMATIC AND ASYMPTOMATIC PATIENTS","ΔΙΑΡΚΕΙΑ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ","Δοκιμασία κοπώσεως","ΚΑΡΔΙΑΚΗ ΣΥΧΝΟΤΗΣ ΠΕΡΑΤΟΣ ΔΟΚΙΜΑΣΙΑΣ","ΣΥΜΠΤΩΜΑΤΙΚΟΙ ΚΑΙ ΑΣΥΜΠΤΩΜΑΤΙΚΟΙ ΑΣΘΕΝΕΙΣ","ΦΑΡΜΑΚΕΥΤΙΚΗ ΛΗΨΗ","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"],"dc:title":["ΣΥΜΒΟΛΗ ΕΙΣ ΤΗΝ ΠΡΟΓΝΩΣΤΙΚΗΝ ΣΗΜΑΣΙΑΝ ΤΩΝ ΠΑΡΑΜΕΤΡΩΝ ΤΗΣ ΔΟΚΙΜΑΣΙΑΣ ΚΟΠΩΣΕΩΣ","CONTRIBUTION TO THE PROGNOSTIC VALUE OF EXERCISE TESTING"],"dc:type":["PhD Thesis"]},"updated_at":"2026-07-24T02:25:14Z"}